1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016

Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Glaucoma Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Glaucoma Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Glaucoma Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Glaucoma Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Glaucoma Surgery Devices Overview 10
3 Products under Development 11
3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development 11
3.2 Glaucoma Surgery Devices - Pipeline Products by Segment 12
3.3 Glaucoma Surgery Devices - Pipeline Products by Territory 13
3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 14
3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 15
3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials 16
4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies 17
4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development 17
4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development 19
5 Glaucoma Surgery Devices Companies and Product Overview 21
5.1 Allergan Plc Company Overview 21
5.1.1 Allergan Plc Pipeline Products and Ongoing Clinical Trials Overview 21
5.2 Anteis S.A. Company Overview 25
5.2.1 Anteis S.A. Pipeline Products and Ongoing Clinical Trials Overview 25
5.3 Assenti, LLC Company Overview 26
5.3.1 Assenti, LLC Pipeline Products and Ongoing Clinical Trials Overview 26
5.4 Camras Vision Company Overview 27
5.4.1 Camras Vision Pipeline Products and Ongoing Clinical Trials Overview 27
5.5 Ellex Medical Lasers Limited Company Overview 28
5.5.1 Ellex Medical Lasers Limited Pipeline Products and Ongoing Clinical Trials Overview 28
5.6 Eye Sonix Company Overview 29
5.6.1 Eye Sonix Pipeline Products and Ongoing Clinical Trials Overview 29
5.7 Galaxy Ophthalmics Inc Company Overview 30
5.7.1 Galaxy Ophthalmics Inc Pipeline Products and Ongoing Clinical Trials Overview 30
5.8 Geuder AG Company Overview 31
5.8.1 Geuder AG Pipeline Products and Ongoing Clinical Trials Overview 31
5.9 Glaukos Corporation Company Overview 33
5.9.1 Glaukos Corporation Pipeline Products and Ongoing Clinical Trials Overview 33
5.10 InnFocus LLC Company Overview 41
5.10.1 InnFocus LLC Pipeline Products and Ongoing Clinical Trials Overview 41
5.11 IPI Singapore Company Overview 44
5.11.1 IPI Singapore Pipeline Products and Ongoing Clinical Trials Overview 44
5.12 iSTAR Medical Company Overview 45
5.12.1 iSTAR Medical Pipeline Products and Ongoing Clinical Trials Overview 45
5.13 Ivantis, Inc. Company Overview 47
5.13.1 Ivantis, Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
5.14 Konan Medical Inc. Company Overview 51
5.14.1 Konan Medical Inc. Pipeline Products and Ongoing Clinical Trials Overview 51
5.15 Kytogenics Pharmaceuticals, Inc. Company Overview 54
5.15.1 Kytogenics Pharmaceuticals, Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
5.16 Massachusetts Eye and Ear Infirmary Company Overview 55
5.16.1 Massachusetts Eye and Ear Infirmary Pipeline Products and Ongoing Clinical Trials Overview 55
5.17 Medtronic plc Company Overview 56
5.17.1 Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 56
5.18 Meir Medical Center Company Overview 58
5.18.1 Meir Medical Center Pipeline Products and Ongoing Clinical Trials Overview 58
5.19 MicroOptx, Inc. Company Overview 59
5.19.1 MicroOptx, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
5.20 Ocular Therapeutix, Inc. Company Overview 60
5.20.1 Ocular Therapeutix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 60
5.21 Oculox Technology Sagl Company Overview 62
5.21.1 Oculox Technology Sagl Pipeline Products and Ongoing Clinical Trials Overview 62
5.22 Ocumatrx Company Overview 63
5.22.1 Ocumatrx Pipeline Products and Ongoing Clinical Trials Overview 63
5.23 OcuTherix, Inc. Company Overview 64
5.23.1 OcuTherix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 64
5.24 OPKO Health, Inc. Company Overview 65
5.24.1 OPKO Health, Inc. Pipeline Products and Ongoing Clinical Trials Overview 65
5.25 OptoLight Vision Technology Company Overview 67
5.25.1 OptoLight Vision Technology Pipeline Products and Ongoing Clinical Trials Overview 67
5.26 PolyActiva Pty Ltd Company Overview 69
5.26.1 PolyActiva Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 69
5.27 Queen's University Company Overview 70
5.27.1 Queen's University Pipeline Products and Ongoing Clinical Trials Overview 70
5.28 Refocus Group, Inc. Company Overview 71
5.28.1 Refocus Group, Inc. Pipeline Products and Ongoing Clinical Trials Overview 71
5.29 SOLX, Inc. Company Overview 73
5.29.1 SOLX, Inc. Pipeline Products and Ongoing Clinical Trials Overview 73
5.30 Tel Aviv University Company Overview 76
5.30.1 Tel Aviv University Pipeline Products and Ongoing Clinical Trials Overview 76
5.31 TonoGuard Ltd. Company Overview 78
5.31.1 TonoGuard Ltd. Pipeline Products and Ongoing Clinical Trials Overview 78
5.32 Transcend Medical, Inc. Company Overview 79
5.32.1 Transcend Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 79
5.33 University of Rostock Company Overview 82
5.33.1 University of Rostock Pipeline Products and Ongoing Clinical Trials Overview 82
5.34 ViSci Ltd. Company Overview 83
5.34.1 ViSci Ltd. Pipeline Products and Ongoing Clinical Trials Overview 83
5.35 Westhouse Medical Services Plc Company Overview 84
5.35.1 Westhouse Medical Services Plc Pipeline Products and Ongoing Clinical Trials Overview 84
6 Glaucoma Surgery Devices- Recent Developments 85
7 Appendix 111
7.1 Methodology 111
7.2 About GlobalData 113
7.3 Contact Us 114
7.4 Disclaimer 114

1.1 List of Tables
Table 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 11
Table 2: Glaucoma Surgery Devices - Pipeline Products by Segment 12
Table 3: Glaucoma Surgery Devices - Pipeline Products by Territory 13
Table 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 14
Table 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 15
Table 6: Glaucoma Surgery Devices - Ongoing Clinical Trials 16
Table 7: Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development 17
Table 8: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 19
Table 9: Allergan Plc Pipeline Products and Ongoing Clinical Trials Overview 21
Table 10: XEN45 - Product Status 22
Table 11: XEN45 - Product Description 22
Table 12: Allergan Plc - Ongoing Clinical Trials Overview 23
Table 13: XEN45 - A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects with Refractory Glaucoma 24
Table 14: XEN45 - Ab Interno Gelatin Stent with Mitomycin-C Combined with Cataract Surgery for Treatment of Open-angle Glaucoma 24
Table 15: XEN45 - Post Market Multicentric Evaluation of the AqueSys XEN Implant in Moderate Primary Open Angle Glaucoma Subjects 24
Table 16: Anteis S.A. Pipeline Products and Ongoing Clinical Trials Overview 25
Table 17: Drainage Viscoelastic Injectable Implant - Product Status 25
Table 18: Drainage Viscoelastic Injectable Implant - Product Description 25
Table 19: Assenti, LLC Pipeline Products and Ongoing Clinical Trials Overview 26
Table 20: Intraocular Pressure Monitoring System - Product Status 26
Table 21: Intraocular Pressure Monitoring System - Product Description 26
Table 22: Camras Vision Pipeline Products and Ongoing Clinical Trials Overview 27
Table 23: Camras Shunt - Product Status 27
Table 24: Camras Shunt - Product Description 27
Table 25: Ellex Medical Lasers Limited Pipeline Products and Ongoing Clinical Trials Overview 28
Table 26: Glaucoma Device - Product Status 28
Table 27: Glaucoma Device - Product Description 28
Table 28: Eye Sonix Pipeline Products and Ongoing Clinical Trials Overview 29
Table 29: Therapeutic Ultrasound Device - Glaucoma - Product Status 29
Table 30: Therapeutic Ultrasound Device - Glaucoma - Product Description 29
Table 31: Galaxy Ophthalmics Inc Pipeline Products and Ongoing Clinical Trials Overview 30
Table 32: Implantable Glaucoma Therapy Device - Product Status 30
Table 33: Implantable Glaucoma Therapy Device - Product Description 30
Table 34: Geuder AG Pipeline Products and Ongoing Clinical Trials Overview 31
Table 35: MikroAug - Product Status 32
Table 36: MikroAug - Product Description 32
Table 37: Glaukos Corporation Pipeline Products and Ongoing Clinical Trials Overview 33
Table 38: GTS400 - Product Status 34
Table 39: GTS400 - Product Description 34
Table 40: iStent Inject - Cataract Surgery - Product Status 35
Table 41: iStent Inject - Cataract Surgery - Product Description 35
Table 42: iStent Inject - Standalone Procedures - Product Status 36
Table 43: iStent Inject - Standalone Procedures - Product Description 36
Table 44: iStent Supra - Product Status 37
Table 45: iStent Supra - Product Description 37
Table 46: Glaukos Corporation - Ongoing Clinical Trials Overview 38
Table 47: iStent Supra - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin 39
Table 48: iStent Supra - A Prospective, Randomized, Controlled, Parallel Groups Evaluation of Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment with Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty 39
Table 49: iStent Inject - Cataract Surgery - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment with One or Two Trabecular Micro-bypass Stents in Conjunction with Cataract Surgery 40
Table 50: iStent Inject - Cataract Surgery - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery 40
Table 51: InnFocus LLC Pipeline Products and Ongoing Clinical Trials Overview 41
Table 52: InnFocus Microshunt - Product Status 41
Table 53: InnFocus Microshunt - Product Description 41
Table 54: InnFocus LLC - Ongoing Clinical Trials Overview 42
Table 55: InnFocus Microshunt - InnFocus MicroShunt FDA clinical trial 43
Table 56: InnFocus Microshunt - Post Market Study to Evaluate Safety and Effectiveness of the InnFocus Microshunt (MIDI Arrow) in Patients with Primary Open Angle Glaucoma 43
Table 57: InnFocus Microshunt - Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) to Relieve Glaucoma Symptoms 43
Table 58: IPI Singapore Pipeline Products and Ongoing Clinical Trials Overview 44
Table 59: Pressure-Sensitive Glaucoma Drainage Device - Product Status 44
Table 60: Pressure-Sensitive Glaucoma Drainage Device - Product Description 44
Table 61: iSTAR Medical Pipeline Products and Ongoing Clinical Trials Overview 45
Table 62: STARflo MINI - Product Status 45
Table 63: STARflo MINI - Product Description 45
Table 64: STARflo Plus Glaucoma Implant - Product Status 46
Table 65: STARflo Plus Glaucoma Implant - Product Description 46
Table 66: Ivantis, Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
Table 67: Hydrus Microstent - Product Status 47
Table 68: Hydrus Microstent - Product Description 47
Table 69: Ivantis, Inc. - Ongoing Clinical Trials Overview 48
Table 70: Hydrus Microstent - A Prospective, Multi-center, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery 49
Table 71: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery 49
Table 72: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus to the iStent for Lowering Intraocular Pressure in Primary Open Angle Glaucoma 50
Table 73: Hydrus Microstent - The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial 50
Table 74: Konan Medical Inc. Pipeline Products and Ongoing Clinical Trials Overview 51
Table 75: Bionocular Analytic Dynamic Pupillometer - Product Status 51
Table 76: Bionocular Analytic Dynamic Pupillometer - Product Description 51
Table 77: Konan Medical Inc. - Ongoing Clinical Trials Overview 52
Table 78: Bionocular Analytic Dynamic Pupillometer - The Detection of Glaucoma Using Pupillography 53
Table 79: Kytogenics Pharmaceuticals, Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
Table 80: MACC-Based Device - Glaucoma Filtering - Product Status 54
Table 81: MACC-Based Device - Glaucoma Filtering - Product Description 54
Table 82: Massachusetts Eye and Ear Infirmary Pipeline Products and Ongoing Clinical Trials Overview 55
Table 83: Pressure Relief Valve Shunt - Product Status 55
Table 84: Pressure Relief Valve Shunt - Product Description 55
Table 85: Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 56
Table 86: CellPlant - Product Status 57
Table 87: CellPlant - Product Description 57
Table 88: Meir Medical Center Pipeline Products and Ongoing Clinical Trials Overview 58
Table 89: Glaucoma Drainage Device - Product Status 58
Table 90: Glaucoma Drainage Device - Product Description 58
Table 91: MicroOptx, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
Table 92: BG Implant Shunt - Product Status 59
Table 93: BG Implant Shunt - Product Description 59
Table 94: Ocular Therapeutix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 60
Table 95: Travoprost Punctum Plug - Product Status 61
Table 96: Travoprost Punctum Plug - Product Description 61
Table 97: Oculox Technology Sagl Pipeline Products and Ongoing Clinical Trials Overview 62
Table 98: Foldable Intraocular Pressure Sensor Device - Product Status 62
Table 99: Foldable Intraocular Pressure Sensor Device - Product Description 62
Table 100: Ocumatrx Pipeline Products and Ongoing Clinical Trials Overview 63
Table 101: CaPRI Device - Product Status 63
Table 102: CaPRI Device - Product Description 63
Table 103: OcuTherix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 64
Table 104: Deep Wave Trabeculoplasty Device - Product Status 64
Table 105: Deep Wave Trabeculoplasty Device - Product Description 64
Table 106: OPKO Health, Inc. Pipeline Products and Ongoing Clinical Trials Overview 65
Table 107: Aquashunt - Product Status 66
Table 108: Aquashunt - Product Description 66
Table 109: OptoLight Vision Technology Pipeline Products and Ongoing Clinical Trials Overview 67
Table 110: Lipshitz Macular Implant For Advanced Glaucoma - Product Status 68
Table 111: Lipshitz Macular Implant For Advanced Glaucoma - Product Description 68
Table 112: PolyActiva Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 69
Table 113: Fully Bioerodible Ocular Implant - Glaucoma - Product Status 69
Table 114: Fully Bioerodible Ocular Implant - Glaucoma - Product Description 69
Table 115: Queen's University Pipeline Products and Ongoing Clinical Trials Overview 70
Table 116: Laser Adjustable Suture - Product Status 70
Table 117: Laser Adjustable Suture - Product Description 70
Table 118: Refocus Group, Inc. Pipeline Products and Ongoing Clinical Trials Overview 71
Table 119: PresVIEW Scleral Implant - Glaucoma - Product Status 72
Table 120: PresVIEW Scleral Implant - Glaucoma - Product Description 72
Table 121: SOLX, Inc. Pipeline Products and Ongoing Clinical Trials Overview 73
Table 122: SOLX Gold Shunt - Product Status 73
Table 123: SOLX Gold Shunt - Product Description 73
Table 124: SOLX, Inc. - Ongoing Clinical Trials Overview 74
Table 125: SOLX Gold Shunt - Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma 75
Table 126: Tel Aviv University Pipeline Products and Ongoing Clinical Trials Overview 76
Table 127: Direct Laser Trabeculoplasty System - Product Status 76
Table 128: Direct Laser Trabeculoplasty System - Product Description 76
Table 129: Glaucoma Implant - Product Status 77
Table 130: Glaucoma Implant - Product Description 77
Table 131: TonoGuard Ltd. Pipeline Products and Ongoing Clinical Trials Overview 78
Table 132: EasyIOP - Product Status 78
Table 133: EasyIOP - Product Description 78
Table 134: Transcend Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 79
Table 135: CyPass Micro-Stent - Product Status 79
Table 136: CyPass Micro-Stent - Product Description 79
Table 137: Transcend Medical, Inc. - Ongoing Clinical Trials Overview 80
Table 138: CyPass Micro-Stent - A Randomized, Prospective Clinical Evaluation of the Safety and Effectiveness of Visco-assisted CyPass Micro-Stent Implantation in Patients with Open Angle Glaucoma 81
Table 139: University of Rostock Pipeline Products and Ongoing Clinical Trials Overview 82
Table 140: PTX-Eluting Microstent - Product Status 82
Table 141: PTX-Eluting Microstent - Product Description 82
Table 142: ViSci Ltd. Pipeline Products and Ongoing Clinical Trials Overview 83
Table 143: Sub-Conjunctival Drug Implant - Product Status 83
Table 144: Sub-Conjunctival Drug Implant - Product Description 83
Table 145: Westhouse Medical Services Plc Pipeline Products and Ongoing Clinical Trials Overview 84
Table 146: Pneumatic Trabeculoplasty System - Product Status 84
Table 147: Pneumatic Trabeculoplasty System - Product Description 84
Table 148: Glossary 112

1.2 List of Figures
Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 11
Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment 12
Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory 13
Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 14
Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 15
Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Glaucoma Therapeutics Market: Overview Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma ...

Ophthalmic Lasers Market by Product Type, Application, & End User - Global Forecast to 2021

Ophthalmic Lasers Market by Product Type, Application, & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The ophthalmic lasers market is projected to reach USD 1,245.4 million by 2021 from USD 970.2 million in 2016, at a CAGR of 5.1%. Increasing prevalence of ophthalmic disorders, increasing prevalence of ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.